Zobrazeno 1 - 10
of 1 333
pro vyhledávání: '"Oncogene Addiction"'
Autor:
Messekher M; Service de pneumologie, pôle cœur-poumons hôpital Arnaud-de-Villeneuve, CHU de Montpellier, 371, avenue du Doyen-Gaston-Giraud, 34295 Montpellier cedex 5, France. Electronic address: merouane.messekher@chu-montpellier.fr., François H; Service de pneumologie, centre hospitalier du Taaone, Tahiti, Polynésie française., Denis MG; Laboratoire de biochimie, CHU de Nantes, Nantes, France., Ferrer-Lopez P; Clinique Mamao, Tahiti, Polynésie française., Bost-Bezeaud F; Service d'anatomie pathologique, centre hospitalier du Taaone, Tahiti, Polynésie française., Mazières J; Service de pneumologie, hôpital Larrey, CHU de Toulouse, Toulouse, France., Parrat E; Service de pneumologie, centre hospitalier du Taaone, Tahiti, Polynésie française.
Publikováno v:
Revue des maladies respiratoires [Rev Mal Respir] 2024 Jun; Vol. 41 (6), pp. 451-454. Date of Electronic Publication: 2024 May 24.
Autor:
Di Marco T; Integrated Biology of Rare Tumors Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy., Mazzoni M; Integrated Biology of Rare Tumors Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy., Greco A; Integrated Biology of Rare Tumors Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy., Cassinelli G; Molecular Pharmacology Unit, Experimental Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Via Amadeo 42, 20133 Milan, Italy. Electronic address: giuliana.cassinelli@istitutotumori.mi.it.
Publikováno v:
Biochemical pharmacology [Biochem Pharmacol] 2024 Oct; Vol. 228, pp. 116254. Date of Electronic Publication: 2024 May 03.
Autor:
Figarol S; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Delahaye C; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Gence R; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Doussine A; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Cerapio JP; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Brachais M; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Tardy C; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Béry N; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Asslan R; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Colinge J; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France., Villemin JP; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France., Maraver A; Institut de Recherche en Cancérologie de Montpellier (IRCM), Inserm, Université de Montpellier, Institut Régional du Cancer de Montpellier (ICM), Montpellier, France., Ferrer I; Unidad de Investigación Clínica de Cáncer de Pulmón, Instituto de Investigación Hospital 12 de Octubre-CNIO, Madrid, Spain., Paz-Ares L; Unidad de Investigación Clínica de Cáncer de Pulmón, Instituto de Investigación Hospital 12 de Octubre-CNIO, Madrid, Spain., Kessler L; Kura Oncology, Inc, Calif, USA., Burrows F; Kura Oncology, Inc, Calif, USA., Lajoie-Mazenc I; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Dongay V; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.; Centre Hospitalier Universitaire (CHU) de Toulouse, service de pneumologie, Toulouse, France., Morin C; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.; Centre Hospitalier Universitaire (CHU) de Toulouse, service de pneumologie, Toulouse, France., Florent A; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Pagano S; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France., Taranchon-Clermont E; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.; Oncopole Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Laboratoire de Biologie Médicale Oncologique, Toulouse, France., Casanova A; Oncopole Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Laboratoire de Biologie Médicale Oncologique, Toulouse, France., Pradines A; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.; Oncopole Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Laboratoire de Biologie Médicale Oncologique, Toulouse, France., Mazieres J; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France.; Centre Hospitalier Universitaire (CHU) de Toulouse, service de pneumologie, Toulouse, France., Favre G; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France. favre.gilles@iuct-oncopole.fr.; Oncopole Claudius Regaud, Institut Universitaire du Cancer de Toulouse-Oncopole, Laboratoire de Biologie Médicale Oncologique, Toulouse, France. favre.gilles@iuct-oncopole.fr., Calvayrac O; Centre de Recherches en Cancérologie de Toulouse (CRCT), Inserm, CNRS, Université de Toulouse, Université Toulouse III Paul Sabatier, Toulouse, France. olivier.calvayrac@inserm.fr.
Publikováno v:
Nature communications [Nat Commun] 2024 Jun 27; Vol. 15 (1), pp. 5345. Date of Electronic Publication: 2024 Jun 27.
Autor:
Langston J; University of Colorado School of Medicine, Department of Radiation Oncology, USA., Patil T; University of Colorado School of Medicine, Division of Medical Oncology, Department of Medicine, USA., Ross Camidge D; University of Colorado School of Medicine, Division of Medical Oncology, Department of Medicine, USA., Bunn PA; University of Colorado School of Medicine, Division of Medical Oncology, Department of Medicine, USA., Schenk EL; University of Colorado School of Medicine, Division of Medical Oncology, Department of Medicine, USA., Pacheco JM; University of Colorado School of Medicine, Division of Medical Oncology, Department of Medicine, USA., Jurica J; University of Colorado School of Medicine, Division of Medical Oncology, Department of Medicine, USA., Waxweiler TV; University of Colorado School of Medicine, Department of Radiation Oncology, USA., Kavanagh BD; University of Colorado School of Medicine, Department of Radiation Oncology, USA., Rusthoven CG; University of Colorado School of Medicine, Department of Radiation Oncology, USA. Electronic address: Chad.Rusthoven@CUAnschutz.edu.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2023 Apr; Vol. 178, pp. 103-107. Date of Electronic Publication: 2023 Feb 08.
Autor:
Otano I; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain. iotanoan@alumni.unav.es.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain. iotanoan@alumni.unav.es., Ucero AC; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Medicine and Physiology Department, School of Medicine, Complutense University of Madrid, Madrid, Spain., Zugazagoitia J; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain.; Tumour Microenvironment and Immunotherapy Research Group, i+12, Madrid, Spain., Paz-Ares L; H12O-CNIO Lung Cancer Clinical Research Unit, Health Research Institute Hospital 12 de Octubre (i+12)/Spanish National Cancer Research Center (CNIO), Madrid, Spain. lpazaresr@seom.org.; Spanish Center for Biomedical Research Network in Oncology (CIBERONC), Madrid, Spain. lpazaresr@seom.org.; Medicine and Physiology Department, School of Medicine, Complutense University of Madrid, Madrid, Spain. lpazaresr@seom.org.
Publikováno v:
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2023 Mar; Vol. 20 (3), pp. 143-159. Date of Electronic Publication: 2023 Jan 13.
Autor:
El Husseini K; Hôpital Cochin, Groupe Hospitalier HUPC, Department of Pneumology, Thoracic Oncology Unit, AP-HP, 27, rue du Faubourg Saint-Jacques, Paris, France., Wislez M; Hôpital Cochin, Groupe Hospitalier HUPC, Department of Pneumology, Thoracic Oncology Unit, AP-HP, 27, rue du Faubourg Saint-Jacques, Paris, France. Electronic address: marie.wislez@aphp.fr.
Publikováno v:
Bulletin du cancer [Bull Cancer] 2021 Jun; Vol. 108 (6), pp. 559-561.
Autor:
Khaliq M; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA., Manikkam M; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA., Martinez ED; Department of Pharmacology, UT Southwestern Medical Center, Dallas, TX, USA.; Hamon Center for Therapeutic Oncology Research, UT Southwestern Medical Center, Dallas, TX, USA., Fallahi-Sichani M; Department of Biomedical Engineering, University of Virginia, Charlottesville, VA, USA. fallahi@virginia.edu.
Publikováno v:
Nature communications [Nat Commun] 2021 Mar 09; Vol. 12 (1), pp. 1536. Date of Electronic Publication: 2021 Mar 09.
Autor:
Bronder D; Genetics Branch, Center for Cancer Research, NCI, NIH, Bethesda, MD, USA.; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK., Bakhoum SF; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2020 Mar 06; Vol. 12 (3), pp. e12017. Date of Electronic Publication: 2020 Feb 18.
Autor:
Salgueiro L; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Buccitelli C; Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Rowald K; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Somogyi K; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Kandala S; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Korbel JO; Genome Biology Unit, European Molecular Biology Laboratory (EMBL), Heidelberg, Germany., Sotillo R; Division of Molecular Thoracic Oncology, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Translational Lung Research Center Heidelberg (TRLC), German Center for Lung Research (DZL), Heidelberg, Germany.
Publikováno v:
EMBO molecular medicine [EMBO Mol Med] 2020 Mar 06; Vol. 12 (3), pp. e10941. Date of Electronic Publication: 2020 Feb 06.
Autor:
Balducci E; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France., Sanekli S; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Bicêtre, Le Kremlin Bicêtre, France., Hugues P; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France., Soubeyrand M; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France., Borie C; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France., Fund X; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France., Desterke C; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France., Aumont C; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Bicêtre, Le Kremlin Bicêtre, France., Faivre J; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France.; INSERM, UMR 785, Centre Hépato-Biliaire, Villejuif, France., Bennaceur-Griscelli A; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; INGESTEM-ESteam Pluripotent Stem Cell Infrastructure, Villejuif, France., Turhan AG; INSERM, Unité Mixte de Recherche (UMR) 935, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Paul Brousse, Villejuif, France.; Assistance Publique-Hôpitaux de Paris, Service D'Hématologie, Hôpital Bicêtre, Le Kremlin Bicêtre, France.; INGESTEM-ESteam Pluripotent Stem Cell Infrastructure, Villejuif, France.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2020 Jan; Vol. 61 (1), pp. 209-212. Date of Electronic Publication: 2019 Aug 29.